Back to Search
Start Over
Adherence to inhaled corticosteroid therapy and treatment escalation in the Swedish adult asthma population.
- Source :
-
Respiratory medicine [Respir Med] 2024 Sep; Vol. 231, pp. 107714. Date of Electronic Publication: 2024 Jun 15. - Publication Year :
- 2024
-
Abstract
- Background: Patients with uncontrolled asthma should be evaluated for medication adherence. This study aimed to identify characteristics associated with poor adherence to inhaled corticosteroids (ICS) and to explore adherence prior to treatment escalation.<br />Methods: This nationwide longitudinal cohort study included adult asthma patients (n = 30880) with a healthcare visit including Asthma Control Test (ACT) and registered in the Swedish National Airway Register between 1 July 2017 and 28 February 2019 (index date). Patient data was crosslinked to other national registers. Treatment steps two years pre- and one year post-index, were identified by prescribed drugs. Poor adherence was defined as Medication Possession Ratio <80 %.<br />Results: Poor adherence was identified in 73 % of patients in treatment steps 2-5, where of 35 % had uncontrolled asthma (ACT≤19). In adjusted models, poor adherence was associated with better disease control; ACT≤19 (OR 0.78, 95 % CI 0.71-0.84), short-acting β2-agonist (SABA) overuse (0.69, 0.61-0.79) and exacerbations (0.79, 0.70-0.89) in steps 2-3. Among patients with uncontrolled asthma, poor adherence was associated with SABA overuse (1.71, 1.50-1.95), exacerbations (1.29, 1.15-1.46), current smoking (1.38, 1.21-1.57) and inversely associated with asthma management education (0.85, 0.78-0.93. Similar results were observed in steps 4-5. When investigating post-index treatment, 53 % remained stationary, 30 % stepped down and 17 % escalated treatment. Prior to escalation, 49 % had poor adherence.<br />Conclusions: Poor ICS adherence was associated with better asthma control. Among uncontrolled patients, poor adherence was associated with SABA overuse and exacerbations. Our result highlights the importance of asthma management education to improve adherence in uncontrolled patients.<br />Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: SP is a former employee at Teva Sweden and current employee at AstraZeneca Sweden. AB reports a grant from AstraZeneca and lecture fees from Chiesi paid to his institution outside the submitted work. CS reports personal fees from AstraZeneca, institutional fees from Chiesi outside the submitted work and institutional fees from Teva for the submitted work. JRK reports personal fees from Novartis and ALK outside the submitted work.<br /> (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Subjects :
- Humans
Administration, Inhalation
Sweden
Male
Female
Adult
Middle Aged
Longitudinal Studies
Adrenergic beta-2 Receptor Agonists administration & dosage
Adrenergic beta-2 Receptor Agonists therapeutic use
Aged
Cohort Studies
Anti-Asthmatic Agents administration & dosage
Anti-Asthmatic Agents therapeutic use
Asthma drug therapy
Medication Adherence statistics & numerical data
Adrenal Cortex Hormones administration & dosage
Adrenal Cortex Hormones therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1532-3064
- Volume :
- 231
- Database :
- MEDLINE
- Journal :
- Respiratory medicine
- Publication Type :
- Academic Journal
- Accession number :
- 38885815
- Full Text :
- https://doi.org/10.1016/j.rmed.2024.107714